Dyspnea News and Research

RSS
Dyspnea or dyspnoea or shortness of breath is a debilitating symptom that is the experience of unpleasant or uncomfortable respiratory sensations.

Further Reading

Direct switch of COPD patients from Seretide to Novartis' Ultibro Breezhaler improves lung function

Direct switch of COPD patients from Seretide to Novartis' Ultibro Breezhaler improves lung function

Recommendations to prevent heart failure hospitalizations

Recommendations to prevent heart failure hospitalizations

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

People with severe emphysema may breathe better after EBV therapy, study shows

People with severe emphysema may breathe better after EBV therapy, study shows

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Researchers aim to examine respiratory effects of body weight in preteens

Researchers aim to examine respiratory effects of body weight in preteens

FDA grants accelerated approval to cancer treatment based on common biomarker

FDA grants accelerated approval to cancer treatment based on common biomarker

CT-measured vascular pruning linked to mortality risk in smokers without COPD

CT-measured vascular pruning linked to mortality risk in smokers without COPD

University of Guelph researcher discovers effective way to treat shortness of breath in heart failure

University of Guelph researcher discovers effective way to treat shortness of breath in heart failure

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda announces accelerated approval from FDA for new lung cancer treatment

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

FDA approves new maintenance therapy for recurrent cancers

FDA approves new maintenance therapy for recurrent cancers

FDA awards accelerated approval to new ovarian cancer drug

FDA awards accelerated approval to new ovarian cancer drug

Philips to highlight connected sleep and respiratory product portfolio at ERS International Congress 2016

Philips to highlight connected sleep and respiratory product portfolio at ERS International Congress 2016

Aerobic exercise training reestablishes cardiac protein quality control system in heart failure rats

Aerobic exercise training reestablishes cardiac protein quality control system in heart failure rats

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Unseen health risks of aortic stenosis: an interview with Dr Shelley Rahman Haley

Unseen health risks of aortic stenosis: an interview with Dr Shelley Rahman Haley

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

Minimally important dyspnoea, fatigue changes in PAH patients defined

Minimally important dyspnoea, fatigue changes in PAH patients defined